10 Mobile Apps for Better Living With MS
December 26, 2017
Community pharmacies ideally placed to help the global fight against hepatitis C
December 26, 2017
Show all

Fighting Cancer One Patient At A Time

Cancer medications geared to fighting genetic mutations are becoming more available.

Allan Brandt, a 63-year-old history of medicine professor at Harvard, seems taken aback to have become part of medical history himself. In 2012, he was diagnosed with acute myeloid leukemia, a deadly cancer that had a potential cure: a bone marrow transplant. His sister was a match, and he went through the two-month-long ordeal twice, only to have the cancer return. “No one is going to do well with a third transplant,” he says grimly.

He was saved by a hot biotech trend: medicines that are targeted to a protein made by a particular gene, often discovered by sequencing the cancer’s DNA. Sometimes they work in only a small number of people, requiring diagnostic testing. In Brandt’s case, Agios Pharmaceuticals, just a 15-minute ride from his Harvard office, had a drug that targeted a genetic mutation he was lucky enough to have. Only a few thousand of the 21,000 people diagnosed with AML each year do.

“This drug wasn’t available at all when I got sick,” Brandt says. “In the period of my illness, I’ve been able to get access to what I consider to be a lifesaving medication, and I’ve returned to health. As somebody who starts with a basic skepticism about medical technology and therapeutics, I have to say there are real possibilities for patients in these new developments.”

What drives drug companies to invest in markets of just a few thousand people? Speed is one reason–big benefits for very sick people mean smaller, shorter studies. One Agios drug, Idhifa, was approved by the Food & Drug Administration just 4 years after clinical trials started–a process that typically takes 12 years. Another reason to invest is price. Agios licensed Idhifa to Celgene, which charges $25,000 a month for it. (Brandt gets his medicine for free, because he’s in a clinical trial.)

Read full article: Fighting Cancer One Patient At A Time

Read Full Article: Fighting Cancer One Patient At A Time

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.